Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines

J Lipid Res. 2001 Oct;42(10):1636-44.

Abstract

Multiple changes in HDL metabolism occur during infection and inflammation that could potentially impair the antiatherogenic functions of HDL. Scavenger receptor class B type I (SR-BI) promotes cholesterol efflux from peripheral cells and mediates selective uptake of cholesteryl ester into hepatocytes, thereby playing a pivotal role in reverse cholesterol transport. We studied the effect of endotoxin (lipopolysaccharide, LPS) and cytokines [tumor necrosis factor (TNF) and interleukin 1 (IL-1)] on hepatic SR-BI mRNA and protein levels in Syrian hamsters. LPS significantly decreased SR-BI mRNA levels in hamster liver. This effect was rapid and sustained, and was associated with a decrease in hepatic SR-BI protein levels. High cholesterol diet did not change hepatic SR-BI mRNA levels, and LPS was able to decrease SR-BI mRNA levels during high cholesterol feeding. TNF and IL-1 decreased SR-BI mRNA levels in the liver, and the effects of TNF and IL-1 were additive. TNF and IL-1 also decreased SR-BI levels in Hep3B hepatoma cells. More importantly, TNF and IL-1 decreased the uptake of HDL cholesteryl ester into Hep3B cells. In addition, we studied the effect of LPS on SR-BI mRNA in RAW 264.7 cells, a macrophage cell line. LPS rapidly decreased SR-BI mRNA levels in RAW 264.7 cells, but the effect was not sustained and did not lead to a reduction in SR-BI protein levels. Our results suggest that the decrease in hepatic SR-BI levels due to LPS and cytokines during infection and inflammation may decrease selective uptake of cholesteryl ester into the liver and result in impaired reverse cholesterol transport.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism*
  • Cholesterol Esters / metabolism
  • Cricetinae
  • Diet
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Humans
  • Inflammation / metabolism
  • Interleukin-1 / pharmacology*
  • Lipid Metabolism
  • Lipopolysaccharides / pharmacology*
  • Lipoproteins / metabolism
  • Liver / drug effects*
  • Liver / metabolism*
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Membrane Proteins*
  • Mice
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Immunologic*
  • Receptors, Lipoprotein*
  • Receptors, Scavenger
  • Scavenger Receptors, Class B
  • Time Factors
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • CD36 Antigens
  • Cholesterol Esters
  • Interleukin-1
  • Lipopolysaccharides
  • Lipoproteins
  • Membrane Proteins
  • RNA, Messenger
  • Receptors, Immunologic
  • Receptors, Lipoprotein
  • Receptors, Scavenger
  • SCARB1 protein, human
  • Scarb1 protein, mouse
  • Scavenger Receptors, Class B
  • Tumor Necrosis Factor-alpha